Macular exanthema due to fumaric acid esters

Annals of Pharmacotherapy

Volumn 37, Issue 2, 2003, Pages 234-236

  Guenther, Claudia H ^a   Wozel, Gottfried ^b   Laske, Jörg ^a   Aschoff, Roland ^b   Meurer, Michael ^b   Mena, Rafaela ^b   Larouche, Marie ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Universitätsklinikum Dresden ^*

Author keywords

Exanthema; Fumaric acid esters

Indexed keywords

FUMARIC ACID DIMETHYL ESTER; STEROID;

AGED; ARTICLE; CASE REPORT; DRUG HYPERSENSITIVITY; FEMALE; HUMAN; LICHEN PLANUS; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; PSORIASIS VULGARIS; RASH;

EID: 0037312626     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002800303700215     Document Type: Article

References (21)

1. Ockenfels HM, Schultewolter T, Ockenfels G. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998;139:390-5.
2. Mrowietz U, Christophers E, Altmeyer P. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 1999;141:424-9.
3. De Jong P, Bezemer AC, Zomerdijk TPL. Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 1996;26:2067-74.
4. Ghoreschi K, Deng C, Hussain R, Reitmeier C, Thomas P, Lovett-Racke A, et al. Fumaric acid ester, an antipsoriatic drug, abolishes the capacity of T cells to induce Th1-mediated autoimmune disease (abstract). Arch Dermatol Res 2002;294:8.
5. Zhu K, Mrowietz U. Inhibition of dendritic cell differentiation by fumaric acid esters. J Invest Dermatol 2001;116:203-8.
6. Stoof TJ, Flier J, Sampat S, Nieboer C, Tensen CP, Boorsma DM. The antipsoriatic drug dimethylfumarate strongly suppresses chemokine production in human keratinocytes and peripheral blood mononuclear cells. Br J Dermatol 2001;144:1114-20.
7. Vandermeeren M, Janssens S, Boergers M, Geysen J, Dimethylfumarate is an inhibitor of cytokine-induced E-selectine, VCAM-1 and ICAM- 1 expression in human endothelial cells. Biochem Biophys Res Commun 1997;234:19-23,
8. , Altmeyer P, Matthes U, Pawlak F. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994;30:977-81.
9. Nieboer C, deHoop D, Langendijk PNJ. Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 1990;2:311-2.
10. Mrowietz U, Christophers E, Altmeyer P. Treatment of psoriasis with fumaric acid esters: results of a prospective mulficentre study, Br J Dermatol 1998;138:456-60.
11. Thio HB, van der Schroeff JG, Nugteren-Huying WM, Vermeer BJ. Long-term systemic therapy with dimethylfumarate and monoethylfumarate (Fumaderm) in psoriasis. J Eur Acad Dermatol Venerol 1995;4:35-40.
12. Ameen M, Russell-Jones R. Fumaric acid esters: an alternative systemic treatment for psoriasis. Clin Exp Dermatol 1999;24:361-4.
13. Altmeyer P, Hartwig R, Matthes U. [Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients.] German. Hautarzt 1996;46:190-6.
14. Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis: results and side-effects of two years of treatment. J Am Acad Dermatol 1992;27:769-71.
15. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
16. Gehring W, Gloor M. [Persistent spontaneous erythema caused by topical use of fumaric acid monoethyl ester - an obligate mast cell degranulafion?] German. Dermatol Monatsschr 1990:176:123-8.
17. Dücker P, Pfeiff B. Adverse reactions to topically applied monoethyl fumarate - two case reports. H+G 1998;65:734-6.
18. Lahti A, Vaananen A, Kokkonen EL, Hannuksela M. Acetylsalicylic acid inhibits non-immunologic contact urticaria. Contact Dermatitis 1987;16:133-5.
19. Dubois A, de Monchy G, Schouten J, Durham S, Golden D, Rak S, et al. (letter). Allergy 1999;54:760-2.
20. De Haan P, von Blomberg-van der Flier BM, de Groot J, Nieboer C, Bruynzeel DP. The risk of sensibilization and contact urticaria upon topical application of fumaric acid derivatives. Dermatology 1994;188:126-30.
21. Lahti A, Maibach HI. Contact urticaria from diethyl fumarate. Contact Dermatitis 1985;12:139-40.